Cargando…
Pancreatic Cancer Biomarkers: Oncogenic Mutations, Tissue and Liquid Biopsies, and Radiomics—A Review
Pancreatic cancer is one of the most fatal malignancies, as approximately 80% of patients are at advanced stages by the time of diagnosis. The main reason for the poor overall survival is late diagnosis that is partially due to the lack of tools for early-stage detection. In addition, there are seve...
Autores principales: | Amaral, Maria João, Oliveira, Rui Caetano, Donato, Paulo, Tralhão, José Guilherme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293428/ https://www.ncbi.nlm.nih.gov/pubmed/36988759 http://dx.doi.org/10.1007/s10620-023-07904-6 |
Ejemplares similares
-
Clinical Impact of Preoperative Biliary Drainage in Patients with Ductal Adenocarcinoma of the Pancreatic Head
por: Amaral, Maria João, et al.
Publicado: (2023) -
Tumor Stroma Area and Other Prognostic Factors in Pancreatic Ductal Adenocarcinoma Patients Submitted to Surgery
por: Amaral, Maria João, et al.
Publicado: (2023) -
Clinicopathological prognostic factors for gallbladder carcinoma: a retrospective study
por: Ramalhosa, Fátima, et al.
Publicado: (2022) -
Leukobiopsy – A Possible New Liquid Biopsy Platform for Detecting Oncogenic Mutations
por: Chennakrishnaiah, Shilpa, et al.
Publicado: (2020) -
Radiomics and liquid biopsy in oncology: the holons of systems medicine
por: Neri, Emanuele, et al.
Publicado: (2018)